ARTICLE | Company News
Biofortuna, Lab901 deal
November 23, 2009 8:00 AM UTC
The companies will co-develop and commercialize an automated PCR detection system for celiac disease and other human leukocyte antigen (HLA) related diseases. The companies will optimize Lab901's Scr...